Cancer diagnostic startup investment opportunity
OncoScreen-CEA Rapid Cancer Test
  • Our cutting-edge antigen technologies ensure precise and reliable test results, enabling early cancer detection across various types while also monitoring treatment responses effectively.
Enhancing Early Cancer Diagnosis

OncoFirm™ Revolutionizing Early Cancer Diagnostics through Cutting-Edge Antigen Technology

Our rapid lateral flow assay technology provides quick insights within minutes for timely interventions.

  • Cutting-edge Cancer Diagnostics
  • AI Optimized Reader
  • Rapid Test Development
  • Highly Specific Biomarkers
  • Target immunotherapies
  • Detected in circulating tumor cells

Point-of-care

Deep, actionable insights while your patients are on-site…

OncoFirm Diagnostics Corp. (a registered Delaware Corporation) for the development of Early Cancer Rapid Tests, we are in a premarket investment phase. Our mission will be in revolutionizing early rapid cancer diagnostics through cutting-edge Antigen Patents, Fluorescent Lateral Flow Tests (FLFTs) and traditional lateral flow assay (LFA) technology for rapid tests. Our proprietary rapid diagnostic solutions utilize various antigens, with highly specific biomarkers linked to cancer progression, to provide accurate, fast, and accessible screening tools. Available to hospitals, clinics, and diagnostic labs, cancer screening and progression programs, research in oncology and infectious diseases…                                       Investor Disclaimer (1)

Enhancing Cancer Diagnosis

OncoFirm™ Revolutionizing Cancer Diagnostics through Cutting-Edge Technology

OncoFirm Diagnostics pioneers rapid cancer tests with advanced technology.

rapid cassette dropper steps
Accurate Testing

Ensure precise cancer diagnostics

rapid cassette dropper
Fast Results

Get fast and actionable results

OnCofirm Rapid Cancer Tests
Specialized Biomarkers

Leverage specific cancer biomarkers

  • Role of Peanut Agglutinin in Cancer Detection

    Posted on
    Peanut agglutinin (PNA) plays a role in cancer detection because it specifically binds to the Thomsen–Friedenreich antigen (T-antigen) — a carbohydrate structure that is hidden in normal cells but exposed…
  • What Causes High Thomsen-Friedenreich antigens

    Posted on
    When it’s exposed, it can be detected by specific antibodies (like peanut agglutinin), and its presence is linked to disease processes. The Thomsen–Friedenreich antigen (T antigen) — sometimes called the…
  • What is Biochemical Diagnostics

    Posted on
    Biochemical diagnostics is the branch of laboratory medicine that uses chemical and biochemical tests to detect, measure, and interpret changes in the body’s biochemical processes for the purpose of diagnosing…
  • Causes of High Alpha Fetoprotein

    Posted on
    Alpha-fetoprotein (AFP) is a protein normally produced by the fetal liver and yolk sac during development. In adults, AFP levels are usually very low, so an elevated AFP can be…
  • AI-Driven Biomarkers: Transforming Early Cancer Detection

    Posted on
    OncoFirm Diagnostics | https://oncofirmdiagnostics.com 1. Executive Summary The intersection of artificial intelligence (AI) and biomarker science is revolutionizing early cancer detection. By leveraging AI algorithms to analyze complex biological signals, OncoFirm…